← Leaderboards
Robert Conrad Brunham
University Of British Columbia
$1,497,357
Attributed
$2,994,713
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $442K · FY2008–18$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,994,713 · 2
By mechanism
R01$2,994,713 · 2
Top collaborators
- Raymond Morris Johnson6 shared
- Leonard J Foster5 shared
Most similar at University Of British Columbia
Same institution · by research overlap
- Leonard J Foster$567,411
Others in their field
Top investigators on “Chlamydia Trachomatis”
- Bala Raja · Luminostics, Inc.$28,624,460
- Michael N Starnbach · Harvard University (Medical School)$24,145,144
- Toni Darville · Univ Of North Carolina Chapel Hill$20,345,023
- Guangming Zhong · University Of Texas Hlth Sci Ctr San Ant$19,835,841
- Deborah Anne Dean · Children'S Hospital &Res Ctr At Oakland$15,916,999
- Raphael H. Valdivia · Duke University$12,244,009
Research focus
Chlamydia TrachomatisChlamydiaT-LymphocyteVaccinesAntigensInfectionDesignMediatingGenerationsChlamydia InfectionsImmunityImmunobiologyBaseInfertilityWomanBinding (Molecular Function)Animal ModelGrantChemical VaccinesCessation Of LifeAmericasCd8b1 GeneFundingGenome
Grant awards (11)
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections$341,486
R01 · FY2018 · AI
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections$347,495
R01 · FY2017 · AI
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections$441,953
R01 · FY2016 · AI
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections$373,558
R01 · FY2015 · AI
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infecti$1
R01 · FY2015 · AI
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infecti$355,399
R01 · FY2014 · AI
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics$226,705
R01 · FY2012 · AI · contact PI
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics$218,060
R01 · FY2011 · AI · contact PI
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics$220,256
R01 · FY2010 · AI · contact PI
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics$216,000
R01 · FY2009 · AI · contact PI
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics$253,800
R01 · FY2008 · AI · contact PI